SWP
NAVB

Stratos Wealth Partners’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Stratos Wealth Partners’s Portfolio NAVB Stock Details NAVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-2,059
Closed -$4K – 960
2018
Q4 		$4K Sell
2,059
-275
-12% -$1.13K ﹤0.01% 876
2018
Q3 		$11K Sell
2,334
-200
-8% -$758 ﹤0.01% 2171
2018
Q2 		$12K Hold
2,534
– – ﹤0.01% 971
2018
Q1 		$18K Hold
2,534
– – ﹤0.01% 2065
2017
Q4 		$18K Sell
2,534
-230
-8% -$1.95K ﹤0.01% 1956
2017
Q3 		$23K Buy
2,764
+390
+16% +$3.31K ﹤0.01% 915
2017
Q2 		$24K Hold
2,374
– – ﹤0.01% 820
2017
Q1 		$27K Buy
2,374
+100
+4% +$1.14K ﹤0.01% 788
2016
Q4 		$29K Buy
+2,274
New +$36.1K ﹤0.01% 710
2016
Q2 		– Sell
-2,127
Closed -$40K – 679
2016
Q1 		$40K Hold
2,127
– – ﹤0.01% 569
2015
Q4 		$57K Hold
2,127
– – ﹤0.01% 570
2015
Q3 		$97K Hold
2,127
– – 0.01% 516
2015
Q2 		$68K Hold
2,127
– – 0.01% 509
2015
Q1 		$68K Sell
2,127
-150
-7% -$5.08K 0.01% 602
2014
Q4 		$86K Hold
2,277
– – 0.02% 489
2014
Q3 		$60K Hold
2,277
– – 0.01% 308
2014
Q2 		$67K Buy
+2,277
New +$73.6K 0.02% 305

Other funds holding NAVB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
ACM
Allred Capital Management Dallas, Texas $275M AUM 18.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Stratos Wealth Partners's NAVB Position: Q1 2019 in Review

Stratos Wealth Partners sold out of Navidea Biopharmaceuticals Inc. (NAVB) in Q1 2019, closing a stake of 2,059 shares — an estimated $4K sold.

Stratos Wealth Partners first reported a position in NAVB in Q2 2014 and held it in 17 quarters. The position peaked at $97K in Q3 2015. 49 funds tracked by Wall St. Rank hold NAVB as of Q1 2019.

  • Stratos Wealth Partners reported no remaining Navidea Biopharmaceuticals Inc. position as of Q1 2019 after selling out during the quarter.
  • Stratos Wealth Partners sold 2,059 Navidea Biopharmaceuticals Inc. shares in Q1 2019, an estimated $4K.
  • Stratos Wealth Partners first reported a position in Navidea Biopharmaceuticals Inc. in Q2 2014 and held it in 17 quarters.
  • Stratos Wealth Partners's Navidea Biopharmaceuticals Inc. position peaked at $97K in Q3 2015.
  • 49 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q1 2019.

Based on Stratos Wealth Partners's 13F filing for Q1 2019, filed 7 May 2019.